May 2022 / MULTI-ASSET SOLUTIONS
PULSe Indicator Spikes Again in Q1 2022
Amid geopolitical and pandemic concerns.
- In the first quarter of 2022, the PULSe indicator spiked in March because of the Russia‑Ukraine conflict and the omicron wave of the coronavirus in China.
- The Pandemic factor also surged in March, as China reported the highest number of daily new cases since March 2020 and the BA.2 variant of omicron hit Europe.
- The Uncertainty and Liquidity factors fell in March as markets started to digest the implications of the Russian sanctions on earnings and credit spreads.
PULSe is a composite indicator that is designed to monitor the state of global financial markets since the coronavirus crisis. It stands for Pandemic, Uncertainty, Liquidity, and Sentiment—four factors that we believe encompass much of the market’s dynamics. High positive values of PULSe are typically a negative sign for market stability.1
The PULSe composite indicator reached another post‑pandemic high in March as the geopolitical tension in Eastern Europe escalated sharply after Russia invaded Ukraine and while the omicron variant of the coronavirus spread in China. It has been abating since, ending the quarter only a little higher than at the start of the year.
The PULSe indicator decreased from its peak in early March, thanks to improvements in the Uncertainty (U) and the Liquidity (L) factors. PULSe was characterized as stable as of March 31, 2022.
The Pandemic (P) factor spiked above the crisis zone before edging back as the BA.2 omicron variant hit Europe and omicron spread rapidly in China. Positive test ratios rose in Europe, indicating the spread of the virus might be broader than reported. Consumer activities were negatively affected as reflected in lower Google retail mobility data.
The economic Uncertainty factor decreased as U.S. oil inventories destocked, long‑term government bond yields surged, and earnings forecasts continued to be revised higher.
The Liquidity factor plummeted as the spreads of U.S. 3‑month commercial paper, Euro IG financials, and U.S. high yield all contracted after their initial surge following the conflict in Ukraine and the sanctions against Russia.
The Sentiment (Se) factor also climbed (i.e., worsened) in March due to the increased equity put/call ratio and extreme S&P 500 Index daily price movements before falling back.
Visualizing the PULSe Indicator
(Fig. 1) Expressed as an average of the four component indicators
Radar Chart Showing the PULSe Indicator and Its Components
(Fig. 2) Radial axes expressed as z‑scores (number of standard deviations from the mean)
The Four Components of PULSe
(Fig. 3) Currently only Pandemic is elevated
In this note, we highlight two factors that contributed meaningfully to the PULSe indicator over the month: The omicron variant spread in China showed signs of peaking, and U.S. oil inventories destocked.
1. The Omicron Variant Spread in China Showed Signs of Peaking
In late March, China reported the highest number of daily new cases since March 2020. More than 40 million people in Shanghai, Shenzhen, and Jilin province came under lockdown. This confirmed the Chinese government’s determination to stick to the dynamic zero‑COVID policy at the expense of economic growth, at least in the near term. But as the lockdown‑related death toll started to mount and basic grocery supply and food distribution in Shanghai encountered obstacles, the public’s view toward reopening was seen to be shifting. COVID‑19 control measures in China’s largest industrial cities had taken a toll on the factory operation and transportation networks, putting additional pressure on global supply chains.
The Omicron Wave in China Showed Signs of Peaking
(Fig. 4) China daily new cases (5‑day average)
On the bright side, shortly after the National People’s Congress in March, the State Council announced a trial scheme for antigen testing. In the same week, China’s state‑owned enterprise Genertec and Pfizer signed a contract for marketing and distributing Paxlovid antiviral medication in China. Furthermore, according to Hong Kong University Medical School’s analysis of the recent virus wave, three doses of Sinovac do reduce the risk of hospitalization by 80%. Our health care research team believes that effective vaccination against severe symptoms, availability of oral antiviral drugs, and home‑based antigen testing are three prerequisites for loosening the restrictions and ultimately reopening the Chinese economy. Given the low percentage of cases with severe symptoms, China modified its COVID‑19 treatment guidelines, which specified that patients with mild symptoms are now required to quarantine at designated places instead of hospitals in order to preserve health care resources.
Toward the end of March, daily new cases in China showed signs of peaking. Nevertheless, in the near term, the spread of the omicron variant is likely to continue to disrupt economic activity. We believe China will need to take more policy actions if it is to achieve what now looks like an ambitious goal of 5.5% gross domestic product growth in 2022.
2. U.S. Oil Inventory Has Destocked
Since mid‑2020, U.S. crude oil inventory had been declining as the global economy reopened and OPEC+ pursued a conservative oil supply strategy. After stabilizing at around 415k barrels in January and February, the inventory level resumed its declining trend in March. While the previous demand‑driven destocking reflected lower economic uncertainty, the recent drop was driven by a supply shock from escalating geopolitical tension in Eastern Europe, which, on the contrary, should signal a deterioration in economic uncertainty.
Russia’s invasion of Ukraine and the subsequent sanctions imposed by the U.S., the UK, and Europe created a shock to the world energy supply with unknown duration and severity. This happened at a time when energy demand from the rest of the world was recovering steadily on the back of economic reopening. The gap between energy supply and demand has profound adverse effects on consumer spending; industrial production; CAPEX investment; and, ultimately, future productivity.
U.S. Crude Oil Inventories Remain Low
(Fig. 5) Crude oil stocks in million barrels
Although the U.S. economy appears to be insulated from the war disruption and is self‑sufficient in oil supply, it cannot operate in a vacuum. Countries that used to rely heavily on Russian oil supply had to switch to other sources, with second order impacts on U.S. oil markets. Despite the U.S. government’s plan to release 1 million barrels of oil per day from its strategic reserves to reduce the demand‑supply gap, U.S. oil inventory inevitably embarked on a declining trend.
Increased energy supply risk rings particularly true for the European Union, which sourced more than 35% of its imported natural gas and almost 23% of its crude oil and petroleum products from Russia in 2020. Portfolio Manager Shinwoo Kim believes that policymakers in key economies are likely to seek to accelerate the push to clean energy to ensure future energy security. The transition would take significant time and investment, providing plentiful opportunities for active stock pickers. In the near term though, governments are expected to take a more pragmatic approach to the pace at which they phase out of legacy sources of energy, as supply security now becomes an important factor in shaping energy policy.
This material is being furnished for general informational and/or marketing purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice, nor is it intended to serve as the primary basis for an investment decision. Prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a reliable indicator of future performance. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested.
The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction.
Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources' accuracy or completeness. There is no guarantee that any forecasts made will come to pass.
The views contained herein are as of the date noted on the material and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.
The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request.
It is not intended for distribution to retail investors in any jurisdiction.
USA – Issued in the USA by T. Rowe Price Associates, Inc., 100 East Pratt Street, Baltimore, MD, 21202, which is regulated by the U.S. Securities and Exchange Commission. For Institutional Investors only.
© 2022 T. Rowe Price. All Rights Reserved. T. ROWE PRICE, INVEST WITH CONFIDENCE, and the Bighorn Sheep design are, collectively and/or apart, trademarks of T. Rowe Price Group, Inc.